standards for antibody testing in mogad
Published 9 months ago • 31 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:46
proposed criteria for the diagnosis of mogad
-
3:21
mog antibody seropositivity in a multi-ethnic population
-
2:28
advancements in mogad diagnosis: key features of the new guidelines
-
1:03
antibody screening tests for autoantibody-mediated neurological disorders
-
1:23
research developments in mogad
-
13:27
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad)
-
1:49
the pathology of ms and mogad: similarities and differences
-
2:01
ms & mogad: differences in response to immunomodulatory therapies
-
28:00
2021 rnds | mog antibody disease (mogad)
-
1:17
predicting relapses in mogad
-
55:39
912. mog antibody disease: diagnosis and treatment guidelines
-
1:32
cosmog: anti-fcrn agent rozanolixizumab for relapse prevention in mogad
-
22:01
2022 pre-rnds | mog antibody disease (mogad)
-
12:10
significance of mog antibodies in csf
-
2:21
meteoroid: phase iii trial of satralizumab in patients with mogad
-
35:29
are you missing myelin oligodendrocyte glycoprotein antibody–associated disease (mogad)?
-
14:17
2020 rnds | what is mog antibody disease (mogad)?
-
51:11
205. mogad and nmosd: is mogad part of nmosd or a distinct diagnosis?
-
5:48
considerations for ngs testing in mtnbc